Marcain Spinal Tung

Bupivacaine, the active ingredient in Marcain Spinal Tung, is a local anesthetic (amide) presented as a sterile solution for infiltration use. It provides regional anesthesia for surgical procedures and spinal anesthesia in adult patients.

GNH USA supplies Marcain Spinal Tung as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Bupivacaine is a long‑acting amide local anesthetic used to achieve regional nerve block.

- Surgical procedures: provides local anesthesia for a variety of operative interventions. - Spinal anesthesia: produces sensory and motor block for lower‑body surgeries and obstetric procedures. - Peripheral nerve blocks: offers targeted analgesia for limb surgeries and postoperative pain control.

Bupivacaine may cause a range of adverse reactions following administration.

Common Side Effects: - Hypotension: transient drop in blood pressure after spinal injection. - Bradycardia: slowed heart rate, especially with high spinal levels. - Dizziness or light‑headedness: related to autonomic blockade. - Injection‑site discomfort: mild pain or burning at the puncture site.

Serious or Rare Side Effects: - Cardiac arrhythmias or cardiac arrest: due to systemic toxicity. - Seizures: result of central nervous system toxicity at high plasma concentrations. - Respiratory depression or apnea: severe CNS depression leading to inadequate breathing. - Prolonged motor block: extended loss of muscle function beyond expected duration. - Allergic reactions: including rash, urticaria, or anaphylaxis.

When using Marcain Spinal Tung, clinicians should observe several safety measures.

- Patient assessment: evaluate cardiovascular and neurological status before administration. - Dose limitation: avoid exceeding the recommended maximum dose for the intended route. - Concurrent CNS depressants: use with caution as additive effects may occur. - Elderly or medically compromised patients: consider dose reduction and close monitoring. - Pregnancy and lactation: reserve use for situations where benefit outweighs potential risk. - Store at controlled room temperature: keep in original container, protect from light and moisture.

Bupivacaine can interact with other medications, influencing safety and efficacy.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): increase risk of cardiotoxicity. - Beta‑blockers: may exacerbate bradycardia and hypotension. - Inhalational anesthetics (e.g., halothane): additive central nervous system depression.

Moderate Interactions (Monitor Closely): - Opioids: potential additive respiratory depression. - Calcium channel blockers: may affect cardiac conduction when combined. - Other local anesthetics: cumulative toxicity risk if combined in the same patient.